DOJ Antitrust Probe Targets Rambus Amid Concerns Over Competitive Practices in Semiconductor Industry

Rambus, the technology company known for its innovations in the semiconductor industry, is facing scrutiny from the U.S. Department of Justice’s Antitrust Division. The company confirmed it received a grand jury subpoena as part of an ongoing investigation into potential antitrust violations. This move signals intensified regulatory attention on industry practices that may hinder competition….

Read More

Caleb Williams’ Trademark Battle Over “Iceman” Nickname Highlights Intellectual Property Challenges in Sports

The recent trademark applications by Chicago Bears quarterback Caleb Williams have sparked a legal contest over the nickname “Iceman,” illustrating the complexities of intellectual property rights in sports. Williams filed four trademark applications on March 16, seeking to capitalize on the moniker he earned following a standout NFL season. This action has ignited a three-way…

Read More

Fenwick & West Expands Patent Litigation Team with Key Hires from Winston & Strawn

Fenwick & West LLP has expanded its patent litigation practice by adding a team of five attorneys from Winston & Strawn LLP. This move enhances Fenwick’s capabilities in telecommunications, hardware, software, and semiconductor sectors. The team includes partners Krishnan (KP) Padmanabhan and Scott Border, who will be based in Fenwick’s New York and Washington, D.C….

Read More

Fenwick & West LLP Expands Patent Litigation Capacity with Strategic Acquisition from Winston & Strawn LLP

On April 29, 2026, Fenwick & West LLP announced the acquisition of a five-lawyer intellectual property team from Winston & Strawn LLP. This strategic move aims to bolster Fenwick’s patent litigation capabilities, particularly in the fields of telecommunications, hardware, software, and semiconductors, a critical focus area for the firm. The new team includes seasoned attorneys…

Read More

Federal Circuit Upholds Cisco Triumph in Centripetal Patent Dispute, Setting Precedent for Detailed Claims

In a notable decision, the Federal Circuit upheld a Virginia federal judge’s ruling in favor of Cisco, finding that the tech giant did not infringe on Centripetal Networks’ cybersecurity patents. The case, which centered on allegations that Cisco’s products violated a trio of patents held by Centripetal, was closely watched by professionals in the field…

Read More

Samsung Prevails in PTAB Dispute Against Maxell, Shaping Video Processing Patent Landscape

The Patent Trial and Appeal Board (PTAB) has dismissed all claims that Samsung Electronics Co. Ltd. contested in two video processing patents owned by Maxell Ltd., marking a significant development in the ongoing patent litigation between the two tech giants. This decision comes after Samsung challenged the validity of Maxell’s patents, arguing that the claims…

Read More

Federal Circuit Invalidates Patents but Upholds $1.68 Million Verdict Against LG in Complex IP Dispute

In a recent development, the Federal Circuit Court has invalidated key claims of digital communications patents held by Constellation Designs LLC. Despite this, LG Electronics Inc. remains liable for a $1.68 million verdict following a jury’s finding of infringement linked to broadcast standards. This decision highlights the complex interplay between patent invalidation and liability for…

Read More

Orrick Enhances IP Expertise with Former USPTO Attorney to Strengthen Client Support in Innovation Protection

Orrick Herrington & Sutcliffe LLP has strategically reinforced its intellectual property capabilities by bringing on a former attorney from the U.S. Patent and Trademark Office (USPTO). This addition is part of Orrick’s ongoing efforts to deepen its expertise in IP law, a crucial area for numerous corporate clients seeking robust protection for their innovations. The…

Read More

Teleflex and Medtronic Settle Patent Dispute, Paving Way for Future Innovation in Medical Device Industry

Teleflex and Medtronic have resolved their legal conflict concerning catheter patents, a case highlighted by the recusal of the presiding judge, who felt unable to decide the matter. This settlement concludes a contentious dispute between the two prominent medical device companies, ensuring that both can now redirect their focus towards innovation in the healthcare sector….

Read More

Teleflex and Medtronic Settle Patent Dispute Over Catheter Technology Amid Industry Shake-Up

Medical device giant Teleflex has reached a settlement with Medtronic to conclude their patent litigation over catheter technology. The resolution comes after a judge acknowledged challenges in proceeding with the case due to complexities inherent in patent disputes. The agreement brings to an end a contentious legal battle that has seen both companies defend their…

Read More

Hikma and Cipla Settle Patent Dispute with Pfizer, Paving Way for Vyndamax Generics

Hikma Pharmaceuticals PLC and Cipla Ltd. have resolved their legal disputes with Pfizer Inc. concerning the development of generic versions of Pfizer’s Vyndamax, a drug used to treat a rare heart condition. This settlement marks a significant moment in the pharmaceutical industry, reflecting the ongoing challenges and negotiations surrounding drug patent rights. Vyndamax, approved by…

Read More

Supreme Court to Weigh Impact of ‘Skinny Labels’ on Generic Drug Market in Patent Dispute

In an upcoming U.S. Supreme Court case set for Wednesday, the “skinny label” dispute over generic drugs will take center stage. The controversy revolves around the extent to which generic drug manufacturers can provide limited labeling to avoid infringing on brand-name drug patents. This pivotal case will feature top-tier legal talent, including an experienced patent…

Read More

Supreme Court Upholds Sanctions in Frivolous Lawsuit Against Google, Emphasizing Legal Integrity

The U.S. Supreme Court has decided not to review the sanctions imposed on attorney William Ramey, affirming the lower court’s ruling that he and his client brought a frivolous patent lawsuit against Google. This denial upholds the $255,000 penalties initially levied by a California judge, who criticized the lawsuit’s merit. Ramey had contended that the…

Read More

CureVac Sues Moderna Over mRNA Vaccine Patent Infringement, Highlighting High-Stakes Biotech Disputes

CureVac, a subsidiary of BioNTech, has initiated a legal battle against Moderna, asserting that its COVID-19 vaccine infringes on several of its patents related to messenger RNA (mRNA) technology. The German company alleges that Moderna has “exploited” its innovations without proper licensing agreements, creating tension in the competitive field of vaccine development. Moderna’s vaccine, one…

Read More

Supreme Court Case on “Skinny Labels” Could Impact Patent Strategies Across Pharmaceuticals and Technology Sectors

As the U.S. Supreme Court prepares to hear oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc. on April 29, legal professionals across various sectors are closely observing the proceedings. The dispute centers on induced infringement, specifically related to “skinny labels” and their role in patent litigation. “Skinny labels” allow generic drug manufacturers…

Read More

U.S. Judge Recusal in Verizon Patent Case Highlights Challenges of Judicial Impartiality

In a notable development, U.S. District Judge Alan Albright has recused himself from a case involving Verizon’s legal dispute with a patent holding company. The case centers around claims that the company attempted to avoid a substantial attorney fee award exceeding $500,000. This decision follows revelations of Judge Albright’s past communications with the patent holder,…

Read More

Supreme Court to Decide on Teva’s Skinny Label Case with Far-Reaching Patent Implications

The U.S. Supreme Court is set to tackle a pivotal case concerning the use of so-called “skinny labels” in the pharmaceutical industry. Scheduled for arguments on Wednesday, the case centers on whether Teva Pharmaceuticals can be held liable for patent infringement after marketing a generic version of the blockbuster heart drug carvedilol. The outcome could…

Read More

Questel Unveils QaECTER: A Cutting-Edge AI Model Transforming Patent Retrieval

In an era of rapidly evolving technological advancements, Questel, a Paris-based intellectual property software and services company, has announced the launch of QaECTER, an AI model developed for semantic patent retrieval. The company claims that this innovative model excels across various metrics, outperforming competing systems even when they are significantly larger in scale. The QaECTER…

Read More

Navigating the AI Revolution: Challenges and Opportunities in Intellectual Property Law

As artificial intelligence continues to integrate into the legal landscape, corporate legal teams and law firms are grappling with its implications for intellectual property protection. The fusion of AI and human talent presents both opportunities and challenges, particularly as traditional IP frameworks struggle to keep pace with technological innovations. The evolving capabilities of AI in…

Read More